Search Results

EMPOWER CLINICS INC is pleased to announce that its subsidiary EPW Curesearch LLC has signed another Research Services Agreement with a leading physician and researcher who will act as a Principal Investigator supporting the provision of Pharmaceutical Research and Clinical Trials Services of the first site in Dallas, TX.

CureSearch for Children’s Cancer has committed $2.5 million to fund a first-in-human, phase I/II clinical trial testing an innovative personalized immunotherapy for pediatric high-grade gliomas, the primary cause of death in children with brain tumors.

Up to $7 million in research awards will accelerate the development of better, less-toxic children’s cancer treatments

Modifi Biosciences announced that the journal Science has published a critical study validating the company’s novel oncology platform based on new classes of molecules that exploit tumor-associated DNA repair defects through direct cancer cell DNA modification.

EMPOWER CLINICS INC an integrated healthcare company with a developing research and clinical trials divisions announces various corporate updates.

The Lupus Research Alliance (LRA) is pleased to announce the appointment of Albert Roy to President and Chief Executive Officer effective September 6, 2022.

September 24 is World Cancer Research Day, and September is Childhood Cancer Awareness Month. BioSpace spoke with leaders from three companies tackling pediatric glioma.

CovidAYACancer.org to Provide Critical Guidance to Patients and Healthcare Professionals [15-April-2020] LOS ANGELES , April 14, 2020 /PRNewswire/ -- In response to the urgent demand for expert guidance during the ongoing coronavirus pandemic, six non-profit Adolescent and Young Adult (AYA) cancer advocacy organizations have launched CovidAYACancer.org , a

Epilepsy Foundation today announced the appointment of Laura Thrall as the Epilepsy Foundation’s new president and chief executive officer (CEO), effective April 13, 2020.